- Research article
- Open Access
A mathematical model of aging-related and cortisol induced hippocampal dysfunction
BMC Neuroscience volume 10, Article number: 26 (2009)
The hippocampus is essential for declarative memory synthesis and is a core pathological substrate for Alzheimer's disease (AD), the most common aging-related dementing disease. Acute increases in plasma cortisol are associated with transient hippocampal inhibition and retrograde amnesia, while chronic cortisol elevation is associated with hippocampal atrophy. Thus, cortisol levels could be monitored and managed in older people, to decrease their risk of AD type hippocampal dysfunction. We generated an in silicomodel of the chronic effects of elevated plasma cortisol on hippocampal activity and atrophy, using the systems biology mark-up language (SBML). We further challenged the model with biologically based interventions to ascertain if cortisol associated hippocampal dysfunction could be abrogated.
The in silicoSBML model reflected the in vivoaging of the hippocampus and increased plasma cortisol and negative feedback to the hypothalamic pituitary axis. Aging induced a 12% decrease in hippocampus activity (HA), increased to 30% by acute and 40% by chronic elevations in cortisol. The biological intervention attenuated the cortisol associated decrease in HA by 2% in the acute cortisol simulation and by 8% in the chronic simulation.
Both acute and chronic elevations in cortisol secretion increased aging-associated hippocampal atrophy and a loss of HA in the model. We suggest that this first SMBL model, in tandem with in vitroand in vivostudies, may provide a backbone to further frame computational cortisol and brain aging models, which may help predict aging-related brain changes in vulnerable older people.
Aging-related neurodegenerative diseases are ever increasing thanks to global demographic changes. Alzheimer's disease (AD) is the most common aging-related neurodegenerative disease; the incidence of which doubles yearly after one's seventh decade. Key symptoms of AD are the loss of declarative memory and decreased cognition which are associated with amyloid plaques and tau neurofibrillary tangle deposition and the depletion of hippocampal neurons [1, 2]. The loss of hippocampal CA1 neurons is particularly associated with hippocampal atrophy and memory deficits in AD . As yet, the exact pathological mechanism underscoring hippocampal degeneration in AD remains elusive; however aging-related factors such as diabetes, vascular disease and stress (elevated cortisol levels) are common risk factors for AD [4–6]. In the elderly, elevated plasma cortisol levels are associated with hippocampal atrophy, suggesting cortisol is involved in hippocampal dysfunction. Furthermore, the negative effects of elevated plasma cortisol levels on cognition in the elderly can be abrogated by blocking plasma cortisol release [7, 8]. This suggests that better plasma cortisol regulation may yield improved hippocampal activity in older people.
Plasma cortisol levels are regulated by the hypothalamic-pituitary-adrenal (HPA) axis and the hippocampus, which interact to form a negative feedback circuit to regulate cortisol release. Cortisol's effect on the hippocampus is mediated through interactions with mineralocorticoid receptors (MR) which increase the firing rate of CA1 neurons. A rise in cortisol levels sufficient to fully saturate MR receptors induces the transcription of inhibitory glucocorticoid receptors (GR) which decrease CA1 neuronal firing in tandem with augmenting negative feedback to the HPA to decrease cortisol secretion .
Cortisol provides tonic activation of hippocampal neurons, which can be useful during stressful situations which require alertness and increased neuronal activity. However, a short term overshoot of normal cortisol plasma levels may induce GR transcription, the inhibition of CA1 neuronal activity, and transient amnesia; the "tip of the tongue" phenomenon some experience during stressful situations. Plasma cortisol thus has a "U" shaped dose dependent effect on the firing potential of hippocampal neurons . In the long term elevated cortisol levels are associated with hippocampal atrophy [11–13]. This has led to suggestions that the chronic pathological effects of elevated cortisol levels may be treated in older people by physiological or pharmacological interventions. For example, plasma cortisol levels can be decreased by simple activities of daily living such as exercise .
Physiological studies on the effects of cortisol on hippocampal function are in abundance, as are computational models of HPA regulation of cortisol synthesis. Yet, despite the growing evidence that cortisol is associated with hippocampal dysfunction, there are no in silicomodels of aging-related effects of cortisol on hippocampal function. The benefit of in silicomodelling lies not only in helping to further define and clarify biological systems, but also in providing a medium through which hypotheses which would be difficult and costly to test in vivo- a particular feature of aging related studies- can be approached. Therefore, to help define the relationship between plasma cortisol, aging and hippocampal function, we used clinical data on HPA function, plasma cortisol levels and hippocampal activity to generate an in silicomodel using the Systems Biology Markup Language (SBML) (Figure 1 and 2).
Effects of chronic and acute changes in cortisol levels on Hippocampal Activity and Atrophy
The model was simulated under normal aging conditions defined as; a loss of neurons, decreased dendritic arborisation, decreased synaptic density in the hippocampus, a loss of secretory cells in the HPA, altered negative feedback from the hippocampus, and a gradual decrease in the circulating plasma levels of cortisol. These aging conditions were set to represent the normal aging processes in the brain of an individual between the ages of 45–90 years (Figure 3, graph A). A simulation of the effects of acute bursts in plasma cortisol levels induced a decrease in hippocampal output (HO) of 30% in tandem with a 19% decrease in hippocampal volume (HV). A chronic increase in cortisol produced a decrease of 40% in HO associated with a 25% decrease in HV (Figure 3, graph B). The application of a biological intervention to decrease cortisol levels resulted in a 7% abrogation of the acute cortisol induced decrease in HO while the intervention abrogated the chronic cortisol decrease in HA by 22% (Figure 3, graph C). This suggests that a biological intervention may be most effective in relation to a decrease in hippocampal atrophy associated with a chronic elevation in cortisol.
B) Sensitivity of plasma cortisol to negative feedback at Hypothalamus, Pituitary and CRH levels
There is an aging-related impairment in the feedback inhibition of cortisol on HPA activity [15, 16]. Therefore, to test the reflexivity and sensitivity of the model to physiologically based changes in cortisol regulation, challenges to negative feedback at the hypothalamus and pituitary were simulated. Negative feedback at the hypothalamus and the pituitary was decreased between 10–50%. A decrease in the rate of feedback at the hypothalamus induced a gradual increase in plasma cortisol in tandem with a drop in kda, the dissociation constant for cortisol at the hypothalmus (Figure 4, graph A). This rise was not continuous; plasma cortisol entered a new steady state almost instantaneously in response to the parameter changes. A maximum basal concentration of 38 ug/dL was reached in response to a 50% increase in kda.
The effect of a change in the rate of negative feedback at the level of the pituitary was examined by decreasing kdc in the range of 10–50%. An alteration in cortisol feedback at the pituitary produced a rise in plasma cortisol in tandem with each increase in kdc, followed by a decrease in plasma cortisol until levels reached a steady state akin to that observed with the default value (Figure 4, graph B).
The next parameter investigated was kcrh,; the rate constant for the secretion of CRH. kcrh was decreased in the range 10–50%, each of which produced significant decreases in basal plasma cortisol levels (Figure 4, graph C). When kcrh decreased by 30, 40 and 50%, the basal plasma cortisol level eventually dropped to zero, reflecting the key role CRH has in the synthesis of cortisol. Conversely when kcrh was increased in the range of 10–50%, gradual increases in basal plasma cortisol levels were observed. Again plasma cortisol levels reached a steady state instantaneously with each parameter change, but plasma cortisol did not continue to rise further after kcrh was increased by 40% (Figure 4, graph D).
Altogether these results suggest the in silicosystem responds to negative feedback in a similar fashion to that reported in biological in vivosystems; ie the hypothalamus, pituitary and CRH hormone production were all reflexive to negative feedback via sensitivity to plasma cortisol levels.
C) Response of the system to decreased negative feedback from the hippocampus
The hippocampus provides tonic negative inhibition to the HPA axis, thus when hippocampal output activity levels are high, so too is the degree of negative inhibition from it to the HPA. When hippocampal activity declines due to increased density of inhibitory synapses, compounded by age, then the degree of negative feedback from the hippocampus to the HPA is lessened, thus an increase in cortisol synthesis is seen. Figure 5 shows the relationship between hippocampal activity and HPA regulation of cortisol levels.
D) Sensitivity of HPA axis to altered cortisol synthesis
A number of studies have suggested cortisol secretion alters with age [2, 17]. The analysis of the effects altered cortisol synthesis commenced by changing kcor (the rate constant for the production of cortisol) in the range 10–50% producing an increase in basal cortisol levels with each parameter increment, with levels reaching a maximum value of 19 ug/dL with the largest parameter alteration. Over time basal plasma cortisol levels returned to the original default value (Figure 6).
These observations suggest that the mechanisms in place to deal with elevations in plasma cortisol (e.g. feedback at the level of the pituitary and hypothalamus) ensured that plasma cortisol did not stay elevated for long, thus showing that the simple in silicosystem reflects the biological HPA regulation of cortisol in vivo.
E) Response of System to Somatic Cortisol Demands
The final parameter examined was kcdeg, the rate constant defining the use of freely available plasma cortisol by somatic tissue. This analysis commenced with an increase of kcdeg in the range of 5–25% which produced a progressive decline in plasma cortisol with each parameter increase, followed by an eventual return to steady state levels (Figure 7, graph A). Conversely, a decrease in the rate of cortisol utilisation by somatic tissue (kcdeg) produced a progressive rise in cortisol. This increase in cortisol continued until a new steady state was reached (Figure 7, graph B), thus illustrating the sensitivity of the system to plasma cortisol usage.
F) Parameter changes to examine daily cortisol rhythm
We introduced diurnal oscillations in cortisol secretion so as to help modelers wishing to study this aspect of the model. We have outlined the changes to the ODEs in the Appendix that are needed to produce the diurnal rhythms and have given an example of how the diurnal rhythm changes with age (Figure 8).
The physiological mechanisms underpinning the association between elevated plasma cortisol and hippocampal atrophy in the elderly are not fully understood. However, it is accepted that the expression and activation of cortisol receptors influences hippocampal neuronal activity, and that elevated plasma cortisol is associated with hippocampal dysfunction and memory loss [10, 18]. The neurotoxic effects of elevated cortisol on the hippocampus most likely involves "allostatic" loading of hippocampal cortisol receptors, accelerated by an aging-related loss of neurons and trophic factors [12, 13]. To help further understand the association between stress and hippocampal function, we used information on aging, the HPA axis, plasma cortisol and hippocampal activity, to simulate the effect of chronic and acute cortisol elevations on the hippocampus.
We recognise that cortisol receptors are present throughout the brain, in limbic, brainstem, and cortical regions, all of which are sensitive to aging-related dysfunction. For example, prefrontal cortical (PFC) neurons contribute to cognitive function, particularly executive function; a decrease in which is found in patients with advanced AD, Parkinson's disease and vascular dementia [19, 20]. Rodent studies have also demonstrated dystrophy of PFC neurons after exposure to elevated cortisol levels . This suggests that the PFC may be an interesting component to add to the current model in other to expand its utility in terms of understanding the relationship between cortisol and cognitive function. However in this first paper, we wished to model the clinically documented, but ill-understood link between elevated plasma cortisol levels and AD type hippocampal dysfunction. Therefore we focused on the atrophy of the hippocampus and activity of CA1 neurons therein, because the hippocampus regulates semantic memory and verbal fluency- cognitive domains which are lost at early stages of AD.
The simulations produced by the model suggest that chronic elevations in cortisol are more detrimental to the hippocampus than a series of acute bursts in cortisol. This may be important for clinicians, in terms of the need to take a continuous series of cortisol measurements from patients rather than a snapshot of their plasma cortisol levels in order to calculate their potential risk of cortisol associated hippocampal dysfunction. We further suggest that it could also be useful to study if the cortisol values which decreased hippocampal output and volume in this simulation mirror ageing-related processes in vivo. The model could also be expanded to include gender differences in chronic stress , which may augment neurotoxic effects of elevated plasma cortisol on hippocampal function in females.
Although SBML modelling is in its embryonic stages, skeletal models of physiological systems which share a common computational platform , may be useful in the future to test a variety of hypothesis not only in relation to aging but also disease processes. A natural limitation of SBML modelling lies not only in the translation of biophysical interactions into biomathematical equations, but also in the availability of clinical data to use to inform the values of parameters in the model. However, despite these limitations it is possible to generate useful systems models of aging-related neurodegenerative processes, which may be expanded and potentially used by clinicians as prognostic aides.
We used a variety of Michaelis-Menten and Hill type rate equations to generate a simple steady state model linking resting cortisol levels with hippocampal output. The effects of aging were simulated using a variety of parameters including neuronal loss, a decrease in growth factors, and simulated producing a gradual decrease in HA and HV, at levels not reported to produce cognitive impairment or dementia.
A simulation of the effects of acute increases in plasma cortisol over time produced a decrease in hippocampal activity of 30% and atrophy of 20% by age 90 years. While a chronic elevation of cortisol levels produced a greater decline in hippocampal activity; 40% and greater loss in hippocampal volume 25% – suggesting a chronic elevation in cortisol may be more detrimental in this system rather than an acute elevation. Interestingly the effects of a biological intervention were found to attenuate the effects of chronic cortisol on the hippocampus more greatly than for acute cortisol elevations. Whether or not this in silicointervention is reflecting a real biological process remains to be tested. In theory cognitive impairment associated with a chronic elevation in plasma cortisol may be as a result of structural tissue damage, or transient receptor activation and up-regulation, remodelling of GC associated synapses or simply reflecting a heightened multi-systemic ageing-processes in susceptible older individuals involving a general decrease in health.
We suggest it would be interesting to clinically assess the circulating levels of cortisol at regular intervals in non-cognitively impaired older people who may be at risk of AD. A prospective study should more fully consolidate the link between plasma cortisol levels and cognitive function in older people, in tandem with the use of models such as this, to ascertain if the extrapolated hypothetical effects of increased cortisol level in the elderly are mirrored by clinical changes in cognition. Furthermore, we realise that this paper is framed on the concept that cortisol may induce hippocampal dysfunction. However, hippocampal dysfunction induced by disease processes may uncouple negative feedback by the hippocampus to HPA and alter regulation of cortisol. Hippocampal lesions in Rhesus monkeys alter circulating plasma cortisol levels [3, 24]. Therefore it may be interesting to study patients with familial AD, which should not be associated with cortisol as a risk factor, so as to understand if hippocampal related disease processes may be the a priori event, which subsequently causes deregulation of cortisol synthesis by the HPA, initiating a self-propelling degenerative process involving ever increasing cortisol levels and increasingly dysfunctional hippocampal neurons.
The physiological system modelled is delineated in a simple physiological diagram and flow chart designed to show the relationship between cortisol and hippocampal function (Fig 1a and 1b). SBML was then used to tie together the physiological variables in the model using biochemistry based mathematical questions relating to enzyme substrate reactions (Michaelis-Menten) and receptor ligand interactions (Hill).
The HPA-axis is one of the most studied biological systems and based on available knowledge, a large number of mathematical models of the HPA-axis have been generated [25, 29]. Such models have focused on recreating the circadian and ultradian rhythms associated with cortisol secretion over 24 hour oscillations. In this paper we were interested in modelling the effects of elevated cortisol levels on hippocampal function over a forty year period. As people age, while it recognised that the circadian rhythms of cortisol secretion are flattened with altered phase and amplitude in older people [30, 31]. In older people with chronic stress disorders, such as post traumatic stress disorders, and in older people with cognitive impairment, cortisol levels are found to be elevated above the normal diurnal or circadian levels . Thus the natural rhythms in cortisol secretion were not focussed on in this first model, rather the impact of age, negative feedback and stress were the main features of the model.
There were two principal model outcomes which we were interested in and which relate to clinically described end points in patients with elevated cortisol levels. The first parameter was hippocampal volume (HV)- indexed to hippocampal atrophy, which was a gross measure of decreased neuronal density and dendritic arborisation. The second parameter as hippocampal output (HO); defined as the combined interaction of CA1 excitatory, inhibitory and aging related signals. The CA1 neuron layer is the major output neuronal subfield in the hippocampus. This parameter does not represent hippocampal output in general; rather a simple measure of its temporal activity particularly in relation to AD and declarative memory.
The full list of model variables is included in Table 1, as are the initial parameter concentrations, and sources used to inform these concentrations, where available. The rate determinants used to define the flow between one variable and another are described in Table 2 and the initial values of the rate constants are detailed in Table 3. The mathematical expressions used to translate the physiological interactions into in silicoequations are further described. In short hippocampal synaptic activity was described using simple input (u) and output (v) terms for the synaptic current (I)[1, 33], involving excitatory (Ue) and inhibitory (Ui) synapses and aging related changes in neuronal density, arborisation and growth factors.
1 HPA Regulation of Cortisol Secretion
The secretion of cortisol via HPA regulation was assumed to be in a "steady-state" and represented using a standard "Michaelis-Menten" type biochemical equations and rate equations (Eq 1–3).
2 Cortisol's Interaction with MR and GR Receptors
The binding of cortisol to CA1 MR receptors was represented using the Hill equation for ligand/receptor binding. The first half of the ordinary differential equation (ODE) represents the generation of MR activity, while the second half of the ODE is a degradation reaction, which is necessary to ensure that MR activity does not rise indefinitely (Eq 4).
The binding of cortisol to GR CA1 hippocampal neurons was expressed also using the Hill equation, and combined with a degradation reaction similar to Eq 4, to ensure that GR receptor activity does not rise indefinitely (Eq 5).
3 Aging of CA1 neurons and cortisol stimulation
The population of neurons in the CA1 region of the hippocampus was defined by combining the stimulation of the neuronal population by neuronal growth factors and MR activity, with the last part of the equation representing the ageing related death of neurons (Eq 6).
A rate constant for the decline of neuronal growth factors with time was also included (Eq 7).
4 Excitatory Input Synapses
Exitatory input synapses (Ue) were defined with reference to the relationship between the neuronal population and excitatory impulses with degradation of neuronal arborisation (Eq 8).
It was assumed that the numbers of excitatory synapses would be related both to the numbers of neuronal branches (dendrites) and also synaptic excitatory signals (Eq 9).
5 Inhibitory Input Synapses
Inhibitory synapses (Ui) were defined by combining the activation of GR receptors with the degradation of synaptic inhibitory signals (Eq 10).
6 Aging related changes in Synaptic Current [Is]
Synaptic current was defined as the net combination of excitatory and inhibitory input synapses (Eq 11).
7 Synaptic Output
Synaptic output (Vs) was defined as a combination of synaptic output with a decline of synaptic output related to time (Eq 12).
8 Hippocampal Atrophy
In the model hippocampus atrophy was defined using an SBML rule which was implemented in MathSBML as detailed below.
9 Hippocampal Tissue Output
The first half of the equation represented the generation of hippocampus output (HO), while the second half of the equation represented the degradation of hippocampus output. The degradation of HO had no biological significance, but served to ensure that hippocampus output did not rise indefinitely when simulations were conducted but instead reached a steady state (Eq 14).
Firstly the system model was brought into a steady state, and the initial hippocampus output was set at 100% which is a mathematical representation of activity, and does not refer to the cognitive ability of the in silicoindividual modelled in this paper.
The response to stress was examined by using events in SBML designed to mirror physiological responses to stress. The first event triggered an increase in the reaction rate kcrh, which raised the secretion of CRH. This in turn precipitated an increase in ACTH, followed by an increase in plasma cortisol. The second event returned kcrh to its original value after a short period of time which produced a yearly increase in cortisol. kcr was not returned to its original value after each event in order so as to represent stress and ageing altering the ability of the HPA-axis to recover from repeated challenges which reflects the clinical hypothesis that ageing impairs homeostatic adaptations of cortisol secretion to stress.(31).
Necessary changes to ODEs to produce a diurnal cortisol rhythm
k1 = 20, k2 = 100, k3 = 1.05, k4 = 1.1, k5 = 0.15, k6 = 0.6, k7 = 10
Scher AI, Xu Y, Korf ES, White LR, Scheltens P, Toga AW, Thompson PM, Hartley SW, Witter MP, Valentino DJ, Launer LJ: Hippocampal shape analysis in Alzheimer's disease: A population-based study. Neuroimage. 2007, 36: 8-18. 10.1016/j.neuroimage.2006.12.036.
Giannakopoulos P, von Gunten A, Kovari E, et al.: Stereological analysis of neuropil threads in the hippocampal formation: relationships with Alzheimer's disease neuronal pathology and cognition. Neuropathol Appl Neurobiol. 2007, 33: 334-343. 10.1111/j.1365-2990.2007.00827.x.
Kril JJ, Hodges J, Halliday G: Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease. Neurosci Lett. 2004, 361 (1–3): 9-12. 10.1016/j.neulet.2004.02.001.
Korf ES, White LR, Scheltens P, Launer LJ: Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care. 2006, 29: 2268-74. 10.2337/dc06-0243.
Korf ES, White LR, Scheltens P, Launer LJ: Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension. 2004, 44: 29-34. 10.1161/01.HYP.0000132475.32317.bb.
Lupien SJ, Schwartz G, Ng YK, et al.: The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings. J Psychiatry Neurosci. 2005, 30: 328-34.
Wright CE, Kunz-Ebrecht SR, Iliffe S, Foese O, Steptoe A: Physiological correlates of cognitive functioning in an elderly population. Psychoneuroendocrinology. 2005, 30: 826-38. 10.1016/j.psyneuen.2005.04.001.
Wright RL, Lightner EN, Harman JS, Meijer OC, Conrad CD: Attenuating corticosterone levels on the day of memory assessment prevents chronic stress-induced impairments in spatial memory. Eur J Neurosci. 2006, 24: 595-605. 10.1111/j.1460-9568.2006.04948.x.
De Kloet ER, Oitzl MS, Joels M, et al.: Brain corticosteroid receptor balance in health and disease. Endocrin Rev. 1998, 19: 269-301. 10.1210/er.19.3.269.
Bennett MC, Diamond DM, Fleshner M, Rose GM: Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 1992, 2: 421-30. 10.1002/hipo.450020409.
Lupien SJ, Ng YK, Fiocco A, Wan N, Pruessner JC, Meaney MJ, Schwartz G, Nair NP: The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings. J Psychiatry Neurosci. 2005, 30: 328-34.
de Leon M, Lupien SJ, de Santi S, Convit A, Tarshish C, Nair NP, Thakur M, McEwen BS, Hauger RL, Meaney MJ: Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neuroscience. 1998, 1: 69-73. 10.1038/271.
Landfield PW, Porter NM: Stress hormones and brain aging; adding injury to insult. Nature Neuroscience. 1998, 1: 3-4. 10.1038/196.
Traustadottir T, Bosch PR, Matt KS: The HPA axis response to stress in women: effects of aging and fitness. Psychoneuroendocrinology. 2005, 30: 392-402. 10.1016/j.psyneuen.2004.11.002.
Wilkinson CW, Peskind ER, Raskind MA: Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging. Neuroendocrinology. 1997, 65: 79-90. 10.1159/000127167.
Wilkinson CW, Petrie EC, Murray SR, Colasurdo EA, Raskind MA, Peskind ER: Human glucocorticoid feedback inhibition is reduced in older individuals: evening study. J Clin Endocrinol Metab. 2001, 86: 545-50. 10.1210/jc.86.2.545.
Hertoghe T: "The multiple hormone deficiency" theory of aging: is human senescence caused mainly by multiple hormone deficiencies?. Ann N Y Acad Sci. 2005, 1057: 448-65. 10.1196/annals.1322.035.
Buss C, Wolf OT, Witt J, Hellhammer DH: Autobiographic memory impairment following acute cortisol administration. Psychoneuroendocrinology. 2004, 29: 1093-6. 10.1016/j.psyneuen.2003.09.006.
Caballol N, Marti MJ, Tolosa E: "Cognitive dysfunction and dementia in Parkinson disease.". Mov Disord. 2007, 22: S358-S366. 10.1002/mds.21677.
Moorhouse P, Rockwood K: "Vascular cognitive impairment: current concepts and clinical developments.". Lancet Neurol. 2008, 7.3: 246-55. 10.1016/S1474-4422(08)70040-1.
Cook SC, Wellman CL: "Chronic stress alters dendritic morphology in rat medial prefrontal cortex.". J Neurobiol. 2004, 60.2: 236-48. 10.1002/neu.20025.
Luine VN, Beck KD, Bowman RE, Frankfurt M, Maclusky NJ: Chronic stress and neural function: accounting for sex and age. J Neuroendocrinol. 2007, 19: 743-51. 10.1111/j.1365-2826.2007.01594.x.
Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, Cuellar AA, Dronov S, Gilles ED, Ginkel M, Gor V, Goryanin II, Hedley WJ, Hodgman TC, Hofmeyr JH, Hunter PJ, Juty NS, Kasberger JL, Kremling A, Kummer U, Le Novère N, Loew LM, Lucio D, Mendes P, Minch E, Mjolsness ED, Nakayama Y, Nelson MR, Nielsen PF, Sakurada T, Schaff JC, Shapiro BE, Shimizu TS, Spence HD, Stelling J, Takahashi K, Tomita M, Wagner J, Wang J, SBML Forum: The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics. 2003, 19: 524-31. 10.1093/bioinformatics/btg015.
Regestein QR, Jackson WJ, Peterson HF: Effects of various hippocampal lesions on monkey plasma cortisol levels in two experimental conditions. Behav Neural Biol. 1986, 45: 329-41. 10.1016/S0163-1047(86)80021-8.
Jelic S, Cupic Z, Kolar-Anic L: Mathematical modeling of the hypothalamic-pituitary-adrenal system activity. Math Biosci. 2005, 197: 173-87. 10.1016/j.mbs.2005.06.006.
Lenbury Y, Pornsawad P: A delay-differential equation model of the feedback-controlled hypothalamus-pituitary-adrenal axis in humans. Math Med Biol. 2005, 22: 15-33. 10.1093/imammb/dqh020.
Brown EN, Meehan PM, Dempster AP: A stochastic differential equation model of diurnal cortisol patterns. Am J Physiol Endocrinol Metab. 2001, 280: E450-61.
Gonzalez-Heydrich J, Steingard RJ, Putnam F, Beardslee W, Kohane IS: Using 'off the shelf', computer programs to mine additional insights from published data: diurnal variation in potency of ACTH stimulation of cortisol secretion revealed. Comput Methods Programs Biomed. 1999, 58: 227-38. 10.1016/S0169-2607(98)00086-8.
Li G, Liu B, Liu Y: A dynamical model of the pulsatile secretion of the hypothalamo-pituitary-thyroid axis. Biosystems. 1995, 35: 83-92. 10.1016/0303-2647(94)01484-O.
Deuschle M, Gotthardt U, Schweiger U, et al.: With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens. Life Sci. 1997, 61: 2239-46. 10.1016/S0024-3205(97)00926-0.
Van Cauter E, Leproult R, Kupfer DJ: Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996, 81: 2468-2473. 10.1210/jc.81.7.2468.
Wolf OT, et al.: "Subjective memory complaints in aging are associated with elevated cortisol levels.". Neurobiol Aging. 2005, 26: 1357-63. 10.1016/j.neurobiolaging.2004.11.003.
Dayan , Peter , Abbott LF: Theoretical Neuroscience. Computational and Mathematical Modeling of Neural Systems. 2001, Cambridge, Mass: MIT Press, xv: 460.
We acknowledge Daryl Shanley, Carole Proctor and Arthur E Oakley for their technical and neuro-anatomical expertise and advice. MT Mc Auley was funded by an EPSRC CASE studentship with Unilever. VM Miller was funded by the Alzheimer's Research Trust UK.
MMA was responsible for the majority of the computational mathematical modeling and sensitivity analysis of the system. VM was responsible for the initial physiological modeling, data mining and assisted the translation of this model to a mathematical based structure. RAK provided clinical information for the model, and TK provided insight into the effects of aging on the system, while DW and JJ advised on the modelling of the system.
All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
McAuley, M.T., Kenny, R.A., Kirkwood, T.B. et al. A mathematical model of aging-related and cortisol induced hippocampal dysfunction. BMC Neurosci 10, 26 (2009). https://doi.org/10.1186/1471-2202-10-26
- Cortisol Level
- Plasma Cortisol
- Mineralocorticoid Receptor
- Cortisol Secretion